BIOMARK TO OPEN A DIAGNOSTIC LABORATORY IN QUÉBEC
![BioMark Lab in Quebec](https://www.biomarkdiagnostics.com/wp-content/uploads/2021/04/BioMark-Lab-in-Quebec-805x503-1.jpg)
Vancouver, British Columbia – (April 29, 2021) – BioMark Diagnostics Inc. (“BioMark”) (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF) is pleased to announce today that its wholly-owned subsidiary BioMark Diagnostic Solutions Inc. (“BDS”) will be operating a diagnostic laboratory in Quebec, Canada, which will primarily serve to advance the clinical validation of its proprietary liquid biopsy […]
BIOMARK ANNOUNCES EXERCISE OF WARRANTS AND GAIN DTC ELIGIBILITY FOR ITS COMMON SHARES
![biomark announces exercise of warrants and gain dtc eligibility for its common shares](https://www.biomarkdiagnostics.com/wp-content/uploads/2021/05/biomark-announces-exercise-of-warrants-and-gain-dtc-eligibility-for-its-common-shares.jpg)
Vancouver, British Columbia – (April 21, 2021) – BioMark Diagnostics Inc. (“BioMark”) (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF) is pleased to announce today the agreement by several long-time strategic accredited investors and insiders to exercise approximately 2,000,000 warrants issued in connection with the Company’s private placement of units completed in April 2019, with the warrant […]
Alberta Research to Spot Early Stage Lung Cancer
![alberta research to spot early stage lung cancer](https://www.biomarkdiagnostics.com/wp-content/uploads/2021/05/alberta-research-to-spot-early-stage-lung-cancer.jpg)
Earlier and faster cancer detection is underway in Alberta Mikenomics | April 6, 2021 Earlier and faster cancer detection is the goal of research underway here in Alberta.With funding from the Spark Grants, The Metabolomics Innovation Centre (TMIC) based at the University of Alberta is leading the new effort. With funding from the Spark Grants, The Metabolomics Innovation Centre (TMIC) based […]
A Simple Blood Test to Detect Lung Cancer
![a simple blood test to detect lung cancer](https://www.biomarkdiagnostics.com/wp-content/uploads/2021/05/a-simple-blood-test-to-detect-lung-cancer.jpg)
A new project funded by the Canadian Cancer Society (CCS) could transform how lung cancer is detected and help save lives. Dr. David Wishart March 18, 2021 A new project funded by the Canadian Cancer Society (CCS) could transform how lung cancer is detected and help save lives. Lung cancer is the most commonly diagnosed […]
Long-Time Cardiologist Dr. Myron Weisfeldt Who “Changed Face of Hopkins” Receiving American Heart Association’s Distinguished Watkins-Saunders Award for Commitment to Overcoming Disparities
![long time cardiologist dr myron award for commitment to overcoming disparities](https://www.biomarkdiagnostics.com/wp-content/uploads/2021/05/long-time-cardiologist-dr-myron-award-for-commitment-to-overcoming-disparities.jpg)
Dr. Myron “Mike” Weisfeldt is the 2021 recipient of the American Heart Association’s distinguished Watkins-Saunders Award. Dr. Myron “Mike” Weisfeldt MARCH 9, 2021 Dr. Myron “Mike” Weisfeldt has been a leader in advancing diversity at Johns Hopkins since the early 1970s and is the 2021 recipient of the American Heart Association’s distinguished Watkins-Saunders Award. “Mike […]
3 Cancer Diagnostic Stocks To Watch Following Roche’s GenMark Buy
![3 cancer diagnostic stocks to watch following roche genmark buy](https://www.biomarkdiagnostics.com/wp-content/uploads/2021/05/3-cancer-diagnostic-stocks-to-watch-following-roche-genmark-buy.jpg)
Biotech companies are showing leadership in early detection of cancer. March 16, 2021 Melanie Schaffer , Benzinga Staff Writer In January, Exact Sciences Corporation EXAS 1.59% announced it completed its acquisition of Thrive Earlier Detection Corp. and got Thrive’s blood-based multi-cancer detection technology. Why It Matters: Early detection of cancer greatly increases the survival rate and smaller biotech companies are showing leadership skills in […]
U of Alberta Researchers Win $120K Grant to Develop Metabolite-Based Lung Cancer Test
![u of alberta researchers win 120 grant to develop metabolite based lung cancer test](https://www.biomarkdiagnostics.com/wp-content/uploads/2021/05/u-of-alberta-researchers-win-120-grant-to-develop-metabolite-based-lung-cancer-test.jpg)
Mar 16, 2021 | staff reporter NEW YORK — BioMark Diagnostics said on Tuesday that its collaborators at the University of Alberta’s Metabolomics Innovation Centre have been awarded a C$150,000 (US$120,327) grant to evaluate the company’s metabolite biomarker panel for early lung cancer detection. The funding is being provided through a cancer technology grant program sponsored by […]
BIOMARK’S COLLABORATOR RECEIVES FUNDING TO VALIDATE ITS BIOMARKER PANEL FOR THE EARLY DETECTION OF LUNG CANCER
![biomarks collaborator receives funding to validate its biomarker panel](https://www.biomarkdiagnostics.com/wp-content/uploads/2021/05/biomarks-collaborator-receives-funding-to-validate-its-biomarker-panel.jpg)
Vancouver, British Columbia – (March 16, 2021) – BioMark Diagnostics Inc. (“BioMark”) (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF) is pleased to announce today that its sponsored research collaboration with The Metabolomics Innovation Centre (TMIC) was successful in receiving funding from the Novel Technology Application in Cancer Prevention and Early Detection Spark Grants competition. This comes […]
Yearly Lung Cancer Scans Are Advised for People 50 and Over With Shorter Smoking Histories
![yearly lung cancer scans are advised for people 50 and over with shorter smoking histories](https://www.biomarkdiagnostics.com/wp-content/uploads/2021/05/yearly-lung-cancer-scans-are-advised-for-people-50-and-over-with-shorter-smoking-histories.jpg)
New advice from an influential panel will make more women and African-Americans eligible for CT scans, but some who need them most may not be able to afford them. By Denise Grady March 9, 2021Updated 3:33 p.m. ET New guidelines from medical experts will nearly double the number of people in the United States who are advised […]
Cancer that went undetected during the pandemic an ‘impending disaster,’ specialists warn
![cancer that went undetected during the pandemic an impending disaster specialists warn](https://www.biomarkdiagnostics.com/wp-content/uploads/2021/05/cancer-that-went-undetected-during-the-pandemic-an-impending-disaster-specialists-warn.jpg)
Screening tests and diagnostic procedures for some cancers dropped off sharply during the first COVID-19 wave Leah Hendry · CBC News · Posted: Feb 02, 2021 4:00 AM ET | Last Updated: February 2 Cancer specialists are bracing for a wave of patients suffering from more advanced disease due to delays in both screening and diagnostic testing during the pandemic. About 60,000 […]